MEX3A and cervical carcinoma: In the future, further studies and more analyses will be performed to extensively investigate the effects of changes in the expression of these genes, especially MEX3A and TTYH3, on the biological behavior, chemotherapy sensitivity, related internal mechanisms, and signaling pathways specifically associated with HPV-negative cervical carcinoma to provide new insights into the early screening and effective treatment of HPV-negative cervical carcinoma.